Phase II single-arm clinical study of teriprizumab combined with low-dose paclitaxel for injection (albumin-bound) in the treatment of advanced gastric cancer that failed first-line treatment and advanced colorectal cancer that failed standard treatment

ABSTRACT: Interventions: Patients with advanced gastric cancer group:teriprizumab combined with low-dose paclitaxel for injection (albumin-bound);Patients with advanced colorectal cancer group:teriprizumab combined with low-dose paclitaxel for injection (albumin-bound) Primary outcome(s): Progression free survival Study Design: Factorial

DISEASE(S): Advanced Gastric Cancer, Advanced Colorectal Cancer

PROVIDER: 85110 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR